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Purpose: Prevalence rates for primary open-angle glaucoma (POAG) are significantly higher in Africans than in European
or Asians. It has been reported recently that mitochondrial DNA (mtDNA) lineages of African origin, excluding L2,
conferred susceptibility to POAG in Saudi Arabia. This prompted us to test the role of mtDNA haplogroups in the incidence
of POAG in the Ghanaian population who has a high frequency of L2 lineages.
Methods: DNA was extracted from two independent cohorts of clinically diagnosed POAG patients (n=373) and healthy
controls (n=451). All patients and controls were from Accra and Tema (the southern region of Ghana). The hypervariable
region-I (HVS-I) and coding regions comprising mtDNA haplogroup diagnostic polymorphisms were polymerase chain
reaction (PCR) amplified and sequenced in all patients and controls and the haplotypes obtained were assorted into
haplogroups and their frequencies compared between cohorts.
Results: No statistically significant differences were found in mtDNA haplogroup frequencies between POAG patients
and matched controls in this cohort for the various mtDNA haplogroups tested.
Conclusions: In this Ghanaian cohort, mtDNA haplogroups do not seem to confer susceptibility to POAG.
Primary open-angle Glaucoma (POAG) is the main cause
of irreversible blindness worldwide [1]. Heritability estimates
evidenced that POAG has a strong genetic component [2]. In
fact, linkage analysis, case-control and genome-wide
association approaches have related more than 20 nuclear
genetic loci to POAG [3]. However, these associations only
account for about 5% of POAG cases, reinforcing the idea that
POAG is a complex multifactorial disorder result of the
interaction of multiple genes and environmental factors [4].
In addition, several epidemiological studies have shown that
a positive maternal family history significantly increases the
risk of developing POAG than a positive paternal family
history [5-7] raising the possibility of an involvement of
maternal cytoplasmic factors, as the mitochondria, in the
transmission and pathogenesis of POAG. A characteristic of
the haploid mitochondrial genome (mtDNA) is its high
mutation rate due to which has accumulated several
polymorphisms, temporal and geographically structured,
reflecting the prehistoric spread of humans from Africa to the
rest of the world [8]. These diagnostic polymorphisms have
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been used to assort related individual mtDNA types
(haplotypes) into groups (haplogroups) following a
hierarchical nomenclature. Major haplogroups were denoted
by uppercase roman letters and successive nested groups by
alternating integers and lowercase roman letters [9]. For
instance, all mtDNA haplotypes of African origin belong to a
macro-haplogroup named “L” that comprises several related
haplogroups named L0, L1, L2, L3, each of which was further
subdivided into sub-haplogroups as L0a, L0b, L0c, and so on.
It has been demonstrated that different haplogroup
backgrounds could modify numerous disease predispositions
[10]. Recently, it has been reported that African mtDNA
haplotypes belonging to L haplogroups, excluding L2, confer
susceptibility to POAG in the Saudi Arabian population [11].
Taking into account the fact that prevalence of POAG in
Africans and populations of African descent is significantly
higher than in Europeans and Asians [12], this report raised
the possibility that some mtDNA African haplogroups were,
at least in part, responsible for the susceptibility of Africans
to POAG. To test this hypothesis, we compared mtDNA
Haplogroups frequencies in POAG patients from Ghana with
that of ethnicity matching controls.
METHODS
Patients and control subjects: We recruited 373 Ghanaian
POAG patients (with a mean age of 62±12) who satisfied strict
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clinical criteria for POAG which includes the following: i)
appearance of the disc or retinal nerve fiber layer e.g., thinning
or notching of disc rim, progressive changes, nerve fiber layer
defect; ii) the presence of characteristic abnormalities in visual
field (e.g., arcuate scotoma, nasal step, paracentral scotoma,
generalized depression) in the absence of other causes or
explanation; iii) age greater than 40 years, and iv) open
anterior chamber angles bilaterally on gonioscopy. Exclusion
criteria included evidence of secondary glaucoma, e.g.,
pigmentary dispersion syndrome, pseudoexfoliation, history
of steroid use or ocular trauma. All cases had onset of
glaucoma after age 40 (adult-onset POAG). Patients were
recruited from the glaucoma clinic in Accra after signing an
informed consent approved by the institutional review board.
A second group (n=451 with a mean age of 53.2±10
years) of healthy Ghanian controls free from glaucoma by
examination were recruited. Entry criteria for those subjects
were age >40, normal IOP, open angles on gonioscopy, and
normal optic nerves on examination.
DNA extraction: Peripheral blood (5 ml) was collected in
EDTA tubes from all participating individuals. DNA was
extracted using the illustra blood genomicPrep Mini Spin Kit
from GE Healthcare (Buckinhamshire, UK), and stored at –
20 °C in aliquots until required.
Mitochondrial haplogroup assortment: All samples were
polymerase chain reaction (PCR) amplified and sequenced for
the mtDNA regulatory region hyper variable segment I (HVS-
I) and, when necessary, for coding segments comprising one
or more additional diagnostic positions (Table 1). Previously
described primers and conditions [13] (Table 2) were used.
Each 25 µl PCR reaction contained 2.5 µl of 10× reaction
buffer with MgCl2 (Amersham Pharmacia Biotech,
Piscataway, NJ), 10 pmol of each primer, 100 pmol/µl each
of deoxynucleoside triphophates (deoxyadenosine
triphosphate, deoxyguanosine triphosphate, deoxycytidine
triphosphate and deoxythymidine triphosphate; Perkin-Elmer
Corporation, Foster City, CA) in Tris HCl buffer, 1 unit Taq
DNA polymerase (Amersham Pharmacia Biotech) and 50 ng
genomic DNA template. The mixture was denatured at 95 °C
for 5 min and the PCR reaction was carried out for 35 cycles,
in a GeneAmp 9700 PCR system (Perkin-Elmer Corporation),
under the following conditions: denaturation at 95 °C for 1
min, annealing at 54 °C for 45 s, extension at 72 °C for 1 min
and final extension cycle of 72 °C for 7 min. The PCR products
were electrophoresed on a 1% agarose gel and detected with
TABLE 1. HAPLOGROUP DISTRIBUTION IN POAG PATIENTS AND CONTROLS.
 
Control (n=451) Case (n=373) Confidence interval 
Haplogroup N % N % Odds
ratio
Lower limit Upper limit Fisher test p-value
L 0 0 1 0.3 - - - 0.45
L0 1 0.2 0 0 - - - 1.00
L0a 11 2.4 11 2.9 1.22 0.52 2.84 0.67
L1b 33 7.3 36 9.7 1.35 0.83 2.22 0.26
L1c 31 6.9 23 6.2 0.89 0.51 1.56 0.78
L2 17 3.8 15 4.0 1.07 0.53 2.17 0.86
L2a 147 32.6 118 31.6 0.96 0.71 1.28 0.82
L2b 27 6.0 12 3.2 0.52 0.26 1.05 0.07
L2c 10 2.2 8 2.1 0.97 0.38 2.47 1.00
L2d 3 0.7 0 0 - - - 0.26
L2e 3 0.7 1 0.3 0.40 0.04 3.88 0.63
L3 6 1.3 1 0.3 0.20 0.02 1.66 0.14
L3a 1 0.2 3 0.8 3.65 0.38 35.22 0.33
L3b 33 7.3 36 9.7 1.35 0.83 2.22 0.26
L3d 43 9.5 24 6.4 0.65 0.39 1.10 0.12
L3e 70 15.5 62 16.6 1.09 0.75 1.58 0.70
L3f 8 1.8 13 3.5 2.00 0.82 4.88 0.13
L3h 0 0 1 0.3 - - - 0.45
L4 2 0.4 2 0.5 1.21 0.17 8.63 1.00
L4b 1 0.2 0 0 - - - 1.00
M1 0 0 1 0.3 - - - 0.45
U6a 4 0.9 5 1.3 1.52 0.40 5.70 0.74
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TABLE 2. PRIMERS USED FOR MITOCHONDRIAL HAPLOGROUPING.
Primer # Primer sequence Annealing temp. Product size
MIT-1-F CCTCCCTGTACGAAAGGACA 57 614
MIT-1-R TGAGATTGTTTGGGCTACTGC   
MIT-2-F CGAGCAGTAGCCCAAACAAT 57 664
MIT-2-R TTTTGGATTCTCAGGGATGG   
MIT-3-F CCATCCCTGAGAATCCAAAA 57 653
MIT-3-R ATTTTGCGTAGCTGGGTCTG   
MIT-4-F TAAACCAGACCCAGCTACGC 55 661
MIT-4-R AAAGTGGCTGATTTGCGTTC   
MIT-5-F TCAACTGAACGCAAATCAGC 60 784
MIT-5-R TGAAATTGATGGCCCCTAAG   
MIT-6-F CTTAGGGGCCATCAATTTCA 57 705
MIT-6-R AAGCCTCCTATGATGGCAAA   
MIT-7-F GCCATCATAGGAGGCTTCATT 59 702
MIT-7-R TTTCCTGAGCGTCTGAGATGT   
MIT-8-F CATCTCAGACGCTCAGGAAA 55 730
MIT-8-R GGGAGGTAGGTGGTAGTTTGTG   
MIT-9-F TACTACCGTATGGCCCACCA 60 781
MIT-9-R AGGCTTGGATTAAGGCGACA   
MIT-10-F ACTGACTATCCTAGAAATCGCTGT 59 741
MIT-10-R GCAGATAGTGAGGAAAGTTGAGC   
MIT-11-F CCACGGACTTCACGTCATTA 59 743
MIT-11-R GGGAGGATATGAGGTGTGAGC   
MIT-12-F GCATTTACCATCTCACTTCTAGG 57 751
MIT-12-R AGTGCGATGAGTAGGGGAAG   
MIT-13-F AGGCACATACTTCCTATTCTACACC 55 740
MIT-13-R TGATATTTGATCAGGAGAACGTG   
MIT-14-F ACTGGGAGAACTCTCTGTGCT 55 740
MIT-14-R ACGAACAATGCTACAGGGATG   
MIT-15-F TCCATAATATTCATCCCTGTAGCA 57 741
MIT-15-R GTGGGTACAGATGTGCAGGA   
MIT-16-F GTTACAATCGGCATCAACCA 55 740
MIT-16-R AGCTTTTCTAGTCAGGTTAGGTCTA   
MIT-17-F CCTCAACCCAAAAAGGCATA 59 745
MIT-17-R GGAGGTCGATGAATGAGTGG   
MIT-18-F ACGCAAAATTAACCCCCTAA 59 742
MIT-18-R GCCTAGGAGGTCTGGTGAGA   
MIT-19-F CCTAGGCGACCCAGACAAT 59 740
MIT-19-R GATAGTTGAGGGTTGATTGCTGTA   
MIT-20-F TGCTTACAAGCAAGTACAGCAAT 57 370
MIT-20-R TGATGTCTTATTTAAGGGGAACG   
MIT-21-F GGCTCACATCACCCCATAAA 55 720
MIT-21-R CATGGGCTACACCTTGACCT   
MIT-22-F GCAAACCCTGATGAAGGCTA 57 632
MIT-22-R GGGGTCTTAGCTTTGGCTCT   
MIT-23-F ACTTTGCAAGGAGAGCCAAA 59 672
MIT-23-R AGGCGGTGCCTCTAATACTG   
MIT-24-F TCACCTCTAGCATCACCAGTATT 57 660
MIT-24-R GGAAGGCGCTTTGTGAAGTA   
HVS-I-F ACT TCA CAA CAA TCC TAA TCC T 60 1200
HVS-I-R CGG AGC GAG GAG AGT AGC AC   
HVS-II-F CAT TTA CCG TAC ATA GCA CA 60 820
HVS-II-R GGG AGG GGG TGA TCT AAA AC   
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0.5 µg/ml ethidium bromide to confirm the correct amplicon
size. Composite haplotypes were assorted into haplogroups
following the most recent mtDNA haplogroup nomenclature
[14].
Data analysis: The frequency of each haplogroup among
cases and controls were compared with the Fisher’s exact test,
and the risk of having the disease if a subject have a certain
haplogroup as compared to not having that specific
haplogroup was estimated by computing odds ratio and its
95% confidence interval. Mean age of males was compared
with the females mean age by t-test. A p-value less than 0.05
was considered significant. There was no need to adjust the
significance level of a statistical test to protect against Type I
errors when multiple comparisons were being made because
we did not find any significant association between any of the
mitochondrial haplogroups and the outcome. All analyses
were performed using SPSS v.13 statistical analysis software
(SPSS Inc., Chicago, IL).
RESULTS
Our cohort consisted of 373 POAG Ghanaian-patients and
451 controls from Accra and Tema in the south of Ghana.
There was a statistical significant difference in age (p=0.0001)
between patients (mean age 62±12 years) and controls (mean
age 53.2±10 years). Table 1 shows the mitochondrial
haplogroup distribution among both groups. The results
presented in Table 1, shows that there was no statistically
significant difference between patients and controls for all
mitochondrial haplogroups tested.
DISCUSSION
A well known risk factor for POAG is African descent. At
least in part, it seems correlated with other risk factors more
prevalent in Africans than in Europeans as thinner corneas,
higher percentage of reported diabetes mellitus, or high blood
pressure [15]. In addition, it has been reported that mtDNA
African L haplogroups, excluding L2, confer susceptibility to
POAG in the Saudi Arabia population [11].
We planned to analyze mtDNA frequencies in an African
population with high prevalence of POAG, not directly related
to the Saudi population and without important ethnic
structuring for mtDNA haplogroup frequencies and POAG
prevalence. It seemed us that the Ghana population fulfilled
these requisites because it has prevalence of POAG
comparable to those in African descent populations of USA,
Barbados or St. Lucia [16]; it is located in West Africa, far
away of the Arabian peninsula and showed a lack of difference
in prevalence among different ethnic groups [16] and a great
homogeneity of mtDNA profiles in this and surrounding west
African countries across different linguistic communities
[17,18]. Consequently, the main aim of this work was to
compare the mtDNA haplogroup frequencies between cohorts
of POAG patients and their age-matched controls in general.
Recently, Fendt et al. [17] performed mtDNA
haplogrouping on 191 Ghanaian subjects. Whereas the cohort
analyzed in this paper are derived from the Ghanaian coastal
cities of Accra and Tema which contain multiple tribal groups,
that analyzed by Fendt, et al. [17] were primarily from the
Akan tribal group in the northern region of the country. The
prevalence of most major mtDNA haplogroups was
significantly different from that in our control population. Due
to these population differences, an analysis comparing cases
and controls in our study was not possible.
We compared the mitochondrial haplogroups distribution
among POAG patients from Accra and Tema with controls
from the same area. The results indicate that there was no
statistically significant difference between patients and
controls for all mitochondrial haplogroups tested. Thus, at
least in this part of Ghana, it seems that mtDNA haplogroups
do not play a role for the development of POAG. Accra and
Tema are located in the deep south of Ghana at the gulf of
Guinea coastline. The sub-Saharan African mtDNA haplroup
L2 had similar frequencies in both POAG patients and
controls and the little difference in frequency was not
statistically significant (p=0.86).
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